WHO experts recommend the use of Takeda’s dengue vaccine QDENGA

Takeda today announced that the World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on Immunization shared recommendations for use of QDENGA® (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003).

Glofitamab Regimen Improves Survival in DLBCL

Data from a phase III trial confirmed the benefit of glofitamab (Columvi) in relapsed or refractory diffuse large B-cell lymphoma (DLBCL), with the bispecific antibody

June 21, 2024

Study analyzes the similarities between near-death experiences and psychedelic experiences

Researchers analyzed the similarities and differences between a near-death experience (NDE) while in a coma and the experience induced by a psychedelic drug.

July 28, 2023

New histone tag discovery offers hope for myelin repair in neurodegenerative diseases

In a groundbreaking study, researchers with the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have identified a distinct histone tag in

August 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.